Better Health,
Brighter Future
For the second year in succession Takeda UK have been awarded PMEA Company of the Year Award 2019
14 February 2020
Takeda UK was announced the winner of the PMEA Company of the Year title at a prestigious awards ceremony on 27th November in central London, and was also the winner of four award categories and highly commended and finalists in two other categories within the programme.
Finalists in:
- Excellence in Collaboration & Partnerships (A Gut Reaction) WINNER
- Excellence in Product Introduction WINNER
- Excellence in Patient Education & Support (Putting the Patient at the Centre) WINNER
- Excellence in Pharma Brand Management WINNER
- Award for Patient-Centricity (Putting the Patient at the Centre) HIGHLY COMMENDED
- Excellence in Building Corporate Reputation & Trust (A Gut Reaction - Inflammatory Bowel Disease) FINALIST
The prestigious Company of the Year award is presented to the pharmaceutical, life science or medical device company that most demonstrates outstanding customer-centric achievement.
Commenting on Takeda UK’s achievement, the independent judging panel said; “Takeda are an extremely impressive operation with a fantastic team ethos. They are forward thinking, lead from the front, live their values and have an impressive list of achievements, whilst successfully navigating a sizeable integration. Their presence within the UK healthcare environment belies their shape and size, and their extremely impressive customer focus is at the heart of what they are about.”
As well as demonstrating an innovative business approach, the patient-centered mindset of Takeda was very influential in securing the overall winning award. Winning the ‘Patient Education & Support’ category and being highly commended for the ‘Patient-Centricity’ category, the oncology team illustrated the company’s strategy for placing patients first and at the centre of everything they do.
The already multiple award-winning ulcerative colitis and Crohn’s patient campaign developed by Takeda was announced the winner of the ‘Collaboration & Partnerships’ category and the programmes were also shortlisted as finalists in the Corporate Reputation & Trust award.
In product introduction and brand management categories; the winner was the ‘Product Introduction’ for non-small cell lung cancer, and the IBD team were announced winners of the ‘Pharma Brand Management’ category.
Commenting on the plethora of awards and the Company of the Year prestigious title, Jon Neal, Takeda UK Managing Director said: “It’s a glowing testament to the entire UK team’s commitment, collaboration, energy and innovation. Whilst simultaneously adjusting to the changes of the acquisition of Shire, the entire team has remained focused, and been true to our values demonstrating, Integrity, Fairness, Honesty & Perseverance, resulting once again in this recognition for Takeda UK.
“Putting patients first is in our bloodstream. While lots of companies say the words, Takeda is different because putting patients first is embedded across our business."
The PMEA Awards are run by PMLiVE’s publisher the PMGroup.
UK/WBC/1707/0005v
Date of preparation: February 2020